RA Capital Management - JANUX THERAPEUTICS INC ownership

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of JANUX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$92,389,772
-10.2%
9,165,652
+5.7%
1.82%
-6.4%
Q2 2023$102,920,544
-1.9%
8,670,6440.0%1.94%
-18.2%
Q1 2023$104,914,792
-8.1%
8,670,6440.0%2.38%
+2.5%
Q4 2022$114,192,381
-2.7%
8,670,6440.0%2.32%
-7.5%
Q3 2022$117,401,000
+10.9%
8,670,6440.0%2.50%
-11.3%
Q2 2022$105,869,000
-14.9%
8,670,6440.0%2.82%
+4.1%
Q1 2022$124,337,000
-27.3%
8,670,6440.0%2.71%
-10.0%
Q4 2021$171,072,000
-8.8%
8,670,6440.0%3.02%
+16.0%
Q3 2021$187,546,000
-13.3%
8,670,6440.0%2.60%
-25.1%
Q2 2021$216,333,0008,670,6443.47%
Other shareholders
JANUX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 8,670,644$187,546,0002.60%
5AM Venture Management, LLC 446,266$9,653,0001.96%
Samsara BioCapital, LLC 411,871$8,909,0001.40%
EcoR1 Capital, LLC 1,411,975$30,541,0001.06%
BVF INC/IL 1,017,314$22,005,0000.86%
Orbimed Advisors 3,466,386$74,978,0000.82%
Logos Global Management LP 247,122$4,811,0000.35%
Woodline Partners LP 300,031$6,490,0000.11%
Parkwood LLC 20,777$449,0000.05%
JANUS HENDERSON GROUP PLC 2,416,404$51,375,0000.02%
View complete list of JANUX THERAPEUTICS INC shareholders